1. Raoult, D., Zumla, A., Locatelli, F., Ippolito, G. & Kroemer, G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress 4, 66-75 (2020). [OpenAIRE]
2. Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature https://doi.org/10.1038/s41586-020-2332-7 (2020).
3. Guha, R. Chemical informatics functionality in R. 2007 18, 16 (2007).
4. Cao, Y., Charisi, A., Cheng, L. C., Jiang, T. & Girke, T. ChemmineR: a compound mining framework for R. Bioinformatics 24, 1733-1734 (2008). [OpenAIRE]
5. Yao, X. et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin. Infect. Dis. https://doi.org/10.1093/ cid/ciaa237 (2020).
6. Tang, W. et al. Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial. BMJ 369, m1849 (2020).
7. Mahevas, M. et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data. BMJ 369, m1844 (2020).
8. Boulware, D. R. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. New Engl. J. Med. https://doi.org/10.1056/ NEJMoa2016638 (2020).
9. Liu, W. et al. Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARSCoV-2 and other acute viral infections: a systematic review and meta-analysis. Can. Med. Assoc. J. https://doi.org/10.1503/ cmaj.200647 (2020).
10. Boya, P. et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22, 3927-3936 (2003).
11. Boya, P. & Kroemer, G. Lysosomal membrane permeabilization in cell death. Oncogene 27, 6434-6451 (2008).
12. Briggs, I. & Barnes, J. C. Actions of opioids on the dorsal root potential of the isolated spinal cord preparation of the neonate rat. Neuropharmacology 26, 469-475 (1987).
13. Zhang, L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science 368, 409-412 (2020).
14. Yuan, S. et al. Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol. Res. https://doi.org/ 10.1016/j.phrs.2020.104960 (2020).
15. Adeoye, A. O., Oso, B. J., Olaoye, I. F., Tijjani, H. & Adebayo, A. I. Repurposing of chloroquine and some clinically approved antiviral drugs as effective therapeutics to prevent cellular entry and replication of coronavirus. J. Biomol. Struct. Dyn. https://doi.org/10.1080/07391102.2020.1765876 (2020).